Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00330980 · ClinicalTrials.gov registry record · Phase 4

Effects of Statin Medications on Mental Processes, Behavior, and Serotonin Levels

A Phase 4 study, sponsored by University of California, San Diego.

Completed
Registry status
Phase 4
Development phase
1,000
Enrollment target

NCT00330980 is a Phase 4 study that has completed, run by University of California, San Diego. The registered enrollment target is 1,000 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00330980, a Phase 4 study, has completed, sponsored by University of California, San Diego.

COMPLETED
Registry status
Phase 4
Development phase
1,000 participants
Enrollment target

Study Summary

Statins are cholesterol-lowering medications that are often prescribed for individuals with high cholesterol and who are at risk for heart disease. Preliminary research has shown that statins may have other effects on the body that are unrelated to the heart. The purpose of this study is to evaluate the impact of statins on mood, mental processes, aggression, and serotonin levels.

Interventions

  • DRUG Placebo
  • DRUG 40 mg Pravastatin (Pravachol)
  • DRUG 20 mg Simvastatin

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2000-04
Est. Completion 2004-03
Phase Phase 4

Sponsor

University of California, San Diego

775 total trials

What the Registry Record Tells You About NCT00330980

The ClinicalTrials.gov registry entry for NCT00330980 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.

NCT00330980 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00330980 about?

NCT00330980 is a clinical study titled "Effects of Statin Medications on Mental Processes, Behavior, and Serotonin Levels". Statins are cholesterol-lowering medications that are often prescribed for individuals with high cholesterol and who are at risk for heart disease. Preliminary research has shown that statins may have other effects on the body that are unrelated to the heart. The purpose of this study is to evaluate...

What is the current status of trial NCT00330980?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,000 participants. The study started on 2000-04. Estimated completion is 2004-03.

What interventions are being tested in trial NCT00330980?

The interventions under investigation include: Placebo (DRUG), 40 mg Pravastatin (Pravachol) (DRUG), 20 mg Simvastatin (DRUG).

Who is sponsoring clinical trial NCT00330980?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.